226 related articles for article (PubMed ID: 16879928)
1. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning.
Tho LM; Glegg M; Paterson J; Yap C; MacLeod A; McCabe M; McDonald AC
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):505-13. PubMed ID: 16879928
[TBL] [Abstract][Full Text] [Related]
2. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer.
Gunnlaugsson A; Kjellén E; Nilsson P; Bendahl PO; Willner J; Johnsson A
Acta Oncol; 2007; 46(7):937-44. PubMed ID: 17851844
[TBL] [Abstract][Full Text] [Related]
3. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer.
Robertson JM; Lockman D; Yan D; Wallace M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):413-8. PubMed ID: 17904305
[TBL] [Abstract][Full Text] [Related]
4. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
Cella L; Ciscognetti N; Martin G; Liuzzi R; Punzo G; Solla R; Farella A; Salvatore M; Pacelli R
Med Dosim; 2009; 34(1):75-81. PubMed ID: 19181259
[TBL] [Abstract][Full Text] [Related]
5. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer.
Baglan KL; Frazier RC; Yan D; Huang RR; Martinez AA; Robertson JM
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):176-83. PubMed ID: 11777636
[TBL] [Abstract][Full Text] [Related]
6. Influence of position and radiation technique on organs at risk in radiotherapy of rectal cancer.
Wang JF; Li H; Xiong H; Huang H; Zou YM
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):741-746. PubMed ID: 27752904
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer.
Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328
[TBL] [Abstract][Full Text] [Related]
8. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
[TBL] [Abstract][Full Text] [Related]
9. Treatment with a belly-board device significantly reduces the volume of small bowel irradiated and results in low acute toxicity in adjuvant radiotherapy for gynecologic cancer: results of a prospective study.
Martin J; Fitzpatrick K; Horan G; McCloy R; Buckney S; O'Neill L; Faul C
Radiother Oncol; 2005 Mar; 74(3):267-74. PubMed ID: 15763307
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: a multi-institutional phase II study (KROG 04-01).
Kim DY; Kim TH; Jung KH; Chang HJ; Lim SB; Choi HS; Jeong SY; Nam TK; Ryu SY; Lee DS; Choi SI; Kang JH; Yoon SC
Dis Colon Rectum; 2006 Nov; 49(11):1684-91. PubMed ID: 16988851
[TBL] [Abstract][Full Text] [Related]
11. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
12. Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model.
Robertson JM; Söhn M; Yan D
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):66-72. PubMed ID: 19665323
[TBL] [Abstract][Full Text] [Related]
13. Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2-3 diarrhoea.
Reis T; Khazzaka E; Welzel G; Wenz F; Hofheinz RD; Mai S
Radiat Oncol; 2015 Jan; 10():30. PubMed ID: 25636703
[TBL] [Abstract][Full Text] [Related]
14. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial.
Koper PC; Jansen P; van Putten W; van Os M; Wijnmaalen AJ; Lebesque JV; Levendag PC
Radiother Oncol; 2004 Oct; 73(1):1-9. PubMed ID: 15465140
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
16. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
Klenova A; Parvanova V; Georgiev R; Gesheva N
J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
[TBL] [Abstract][Full Text] [Related]
18. Acute diarrhea during pelvic irradiation: is small-bowel volume effect different in gynecologic patients with prior abdomen operation or not?
Huang EY; Hsu HC; Yang KD; Lin H; Wang FS; Sun LM; Tsai CC; Changchien CC; Wang CJ
Gynecol Oncol; 2005 Apr; 97(1):118-25. PubMed ID: 15790447
[TBL] [Abstract][Full Text] [Related]
19. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
[TBL] [Abstract][Full Text] [Related]
20. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
Rodríguez N; Algara M; Foro P; Lacruz M; Reig A; Membrive I; Lozano J; López JL; Quera J; Fernández-Velilla E; Sanz X
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):810-7. PubMed ID: 18755556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
